{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:01Z","timestamp":1790802661621,"version":"4.1.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Liver transplantation (LT) generally provides superior long-term survival compared with surgical resection (SR) for hepatocellular carcinoma (HCC), but optimal treatment selection remains challenging due to donor scarcity and patient heterogeneity.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To develop and validate a machine learning (ML)\u2013based decision-support model to estimate optimized individualized treatment selection between LT and SR in HCC.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This nationwide cohort study included patients with HCC who underwent either LT or SR between 2008 and 2018 from the Korea Central Cancer Registry as the derivation cohort. An independent cohort of patients with HCC treated between 2009 and 2020 at Seoul St Mary\u2019s Hospital was used for external validation. Data were analyzed from February to March 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Curative treatment with LT or SR for HCC.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Separate ML models estimating 3-year overall survival (OS) were developed for LT and SR. Patients were stratified into high- and low-risk groups for each treatment, identifying LT-favorable and LT-nonfavorable groups. Counterfactual analysis evaluated OS differences between ML-guided and clinical practice treatments.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 3915 patients (3137 [80.1%] male), 296 in the LT group (median [IQR] age, 54.0 [49.0-60.0] years) and 3619 in the SR group (median [IQR] age, 58.0 [51.0-66.0] years), were included in the derivation cohort, and 614 patients (497 [80.9%] male)\u2014314 in the LT group (median [IQR] age, 55.0 [51.0-60.0] years) and 300 in the SR group (median [IQR] age, 59.0 [52.0-66.0] years)\u2014were included in the external validation cohort. Across both cohorts, LT recipients were generally younger and had more advanced liver disease, with higher rates of cirrhosis (78 [26.4%] vs 699 [19.3%];\n P<\/jats:italic>\n \u2009=\u2009.005), hepatic encephalopathy (20 [6.8%] vs 10 [0.3%];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and ascites (50 [19.9%] vs 153 [4.2%];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). LT recipients also exhibited poorer liver function, with lower albumin levels (median [IQR], 3.4 [2.8-4.0] vs 4.2 [3.9-4.5] g\/dL), higher bilirubin levels (median [IQR], 1.4 [0.9-2.5] vs 0.7 [0.5-1.0] mg\/dL), and prolonged international normalized ratios (median [IQR], 1.2 [1.1-1.5] vs 1.1 [1.0-1.1]), and had smaller tumors (median [IQR], 2.3 [1.5-3.6] vs 3.2 [2.2-5.0] cm;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) but more tumors (mean [SD], 1.6 [1.0] vs 1.2 [0.7];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). The support vector machine model achieved the highest area under the receiver operating characteristic curve (AUROC) of 0.82 (95% CI, 0.78-0.86) in the LT cohort, whereas CatBoost performed best in the SR cohort (AUROC, 0.79 [95% CI, 0.78-0.80]). Counterfactual analysis estimated that ML-guided treatment decisions could improve survival compared with observed clinical practice decisions (HR, 0.46 [95% CI, 0.42-0.50];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). These findings were consistent in the independent cohort.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Findings from this cohort study of patients with HCC indicated that an ML-based decision-support model estimated accurate risk stratification and identified the potential for improved survival through individualized, model-guided treatment selection. These findings suggest clinical utility in supplementing existing guidelines.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.32353","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:00:34Z","timestamp":1758121234000},"page":"e2532353","source":"Crossref","is-referenced-by-count":9,"title":["Machine Learning\u2013Based Selection of Resection vs Transplant and Survival in Hepatocellular Carcinoma"],"prefix":"10.1001","volume":"8","author":[{"given":"Hyun Uk","family":"Kim","sequence":"first","affiliation":[{"name":"College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Han","sequence":"additional","affiliation":[{"name":"The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Republic of Korea"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Soo","family":"Sung","sequence":"additional","affiliation":[{"name":"The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Republic of Korea"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Jang","sequence":"additional","affiliation":[{"name":"The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Republic of Korea"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[{"name":"The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Republic of Korea"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Joong","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seoul St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kyoung","family":"You","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seoul St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"issue":"2","key":"zoi250914r1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma.","volume":"82","author":"Sangro","year":"2025","journal-title":"J Hepatol"},{"issue":"3","key":"zoi250914r2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification.","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"2","key":"zoi250914r3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/TP.0b013e3182a89383","article-title":"Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.","volume":"97","author":"Zheng","year":"2014","journal-title":"Transplantation"},{"issue":"6","key":"zoi250914r4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/lt.24758","article-title":"Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: an attempt to perform an ideal meta-analysis.","volume":"23","author":"Menahem","year":"2017","journal-title":"Liver Transpl"},{"issue":"1","key":"zoi250914r5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.21037\/hbsn-21-350","article-title":"Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients.","volume":"11","author":"Koh","year":"2022","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"2","key":"zoi250914r6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3350\/cmh.2023.0099","article-title":"Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: an Asian perspective comparison.","volume":"29","author":"Cho","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"zoi250914r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.2484","article-title":"Trends in outcomes for marginal allografts in liver transplant.","author":"Zhang","year":"2020","journal-title":"JAMA Surg"},{"issue":"6","key":"zoi250914r8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jceh.2023.06.007","article-title":"Long term complications of immunosuppression post liver transplant.","volume":"13","author":"Mehtani","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"5","key":"zoi250914r9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/SLA.0b013e3181a38eb5","article-title":"Predictors of survival after resection of early hepatocellular carcinoma.","volume":"249","author":"Nathan","year":"2009","journal-title":"Ann Surg"},{"issue":"3","key":"zoi250914r10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3350\/cmh.2020.0292","article-title":"Outcomes after liver transplantation in Korea: incidence and risk factors from Korean transplantation registry.","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Mol Hepatol"},{"issue":"13","key":"zoi250914r11","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.3390\/jcm10132869","article-title":"Tailored prediction model of survival after liver transplantation for hepatocellular carcinoma.","volume":"10","author":"Jamtani","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"zoi250914r12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ejso.2021.09.012","article-title":"Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients.","volume":"48","author":"Beumer","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"zoi250914r13","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.3350\/cmh.2024.0323","article-title":"Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation.","volume":"31","author":"Sha","year":"2025","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"zoi250914r14","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jamcollsurg.2018.03.025","article-title":"Proposal of prognostic survival models before and after liver resection for hepatocellular carcinoma in potentially transplantable patients.","volume":"226","author":"Di Sandro","year":"2018","journal-title":"J Am Coll Surg"},{"issue":"3","key":"zoi250914r15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12072-022-10321-y","article-title":"Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study.","volume":"16","author":"Liu","year":"2022","journal-title":"Hepatol Int"},{"issue":"5","key":"zoi250914r16","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2589-7500(21)00040-6","article-title":"Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal data.","volume":"3","author":"Nitski","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"1","key":"zoi250914r17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12874-020-01153-1","article-title":"Survival prediction models since liver transplantation - comparisons between Cox models and machine learning techniques.","volume":"20","author":"Kantidakis","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"zoi250914r18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/ol.2023.13861","article-title":"Development of preoperative and postoperative machine learning models to predict the recurrence of huge hepatocellular carcinoma following surgical resection.","volume":"26","author":"Zhang","year":"2023","journal-title":"Oncol Lett"},{"issue":"4","key":"zoi250914r22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"4","key":"zoi250914r23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.15388\/21-INFOR468","article-title":"Counterfactual explanation of machine learning survival models.","volume":"32","author":"Kovalev","year":"2021","journal-title":"Informatica"},{"issue":"44","key":"zoi250914r24","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.3748\/wjg.v19.i44.7922","article-title":"Liver function impairment in liver transplantation and after extended hepatectomy.","volume":"19","author":"Serenari","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"6","key":"zoi250914r25","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"zoi250914r26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/hep.30278","article-title":"Is it time to reconsider the Milan criteria for selecting patients with hepatocellular carcinoma for deceased-donor liver transplantation?","volume":"69","author":"Costentin","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"zoi250914r27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2016-000129","article-title":"Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? a comparison of eight guidelines.","volume":"4","author":"Manzini","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"issue":"s1","key":"zoi250914r28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/liv.12713","article-title":"Treatment of hepatocellular carcinoma: beyond international guidelines.","volume":"35","author":"Colombo","year":"2015","journal-title":"Liver Int"},{"issue":"2","key":"zoi250914r29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/j.gastro.2014.08.045","article-title":"Challenges to liver transplantation and strategies to improve outcomes.","volume":"148","author":"Dutkowski","year":"2015","journal-title":"Gastroenterology"},{"issue":"13","key":"zoi250914r30","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-23-3978","article-title":"A machine learning algorithm facilitates prognosis prediction and treatment selection for Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma.","volume":"30","author":"Han","year":"2024","journal-title":"Clin Cancer Res"},{"key":"zoi250914r31","doi-asserted-by":"publisher","DOI":"10.1177\/11769351241272397","article-title":"Prediction of treatment recommendations via ensemble machine learning algorithms for non-small cell lung cancer patients in personalized medicine.","author":"Moon","year":"2024","journal-title":"Cancer Inform"},{"issue":"8","key":"zoi250914r32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s42256-021-00353-8","article-title":"Machine learning to guide the use of adjuvant therapies for breast cancer.","volume":"3","author":"Alaa","year":"2021","journal-title":"Nat Mach Intell"},{"key":"zoi250914r33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijsu.2020.05.071","article-title":"Current status of liver transplantation in Asia.","volume":"82S","author":"Hibi","year":"2020","journal-title":"Int J Surg"},{"issue":"4","key":"zoi250914r34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jhep.2021.05.036","article-title":"Why are there so many liver transplants from living donors in Asia and so few in Europe and the US?","volume":"75","author":"Rela","year":"2021","journal-title":"J Hepatol"},{"key":"zoi250914r19","author":"Chen","year":"2016"},{"key":"zoi250914r20","author":"Ke","year":"2017"},{"key":"zoi250914r21","author":"Prokhorenkova","year":"2018"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2839032\/kim_2025_oi_250914_1757519911.88655.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:00:35Z","timestamp":1758121235000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2839032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.32353","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]}}}